Skip to main content

Posts

Showing posts with the label health tech

The சிறப்புச் சட்டமன்றம் deferred the Cauvery water dispute hearing to September

1 செப்டம்பர் 2026, மதியம் 12:03 PM தமிழ்நாடு: Times of India - India அறிவித்த விவரத்தின்படி, the Supreme Court deferred the Cauvery water dispute hearing to September 15 Delhi Police moves SC to withdraw 13 FIRs, including 10 on attempt to murder SG seeks hearing on Sep 1; CJP had விதித்துள்ளார் Centre of reneging on withdrawal of FIRs. Notices were sent to the Centre, with the case scheduled for a hearing on September tenth, urging both protesters and law enforcement to comply with legal standards. SC: Externment orders cannot be அனுமதித்தது routinely, require reasons. Bihar, Jharkhand settle 25-year Sone water row Bihar and Jharkhand resolved a 25-year water dispute on Monday. The Sone river agreement was signed in New Delhi with Union Home Minister Amit Shah. MEA: 51 Indians die serving in Russian army. இந்த தகவல் 2 ஆதாரங்களால் (Times of India - India, Indian Express - India) உறுதிப்படுத்தப்பட்டுள்ளது. அடுத்த என்ன? சட்ட நிலைமை தொடரும், அடுத்த விசாரணிகள் அமைக்கப்பட்ட...

Why Novo Nordisk and OpenAI’s Drug Discovery Deal Matters

When a company as large as Novo Nordisk teams up with OpenAI, the signal is bigger than a single partnership announcement. This is another marker that artificial intelligence is shifting from demo culture into serious industrial workflows, especially in sectors where the upside is massive and the tolerance for sloppy experimentation is basically zero. Reuters reported that Novo Nordisk, the company behind Wegovy, is partnering with OpenAI to accelerate parts of drug development. That matters because pharma is one of the few industries where hype gets stress-tested fast. If a tool cannot improve research velocity, decision quality, or cost structure in a regulated environment, it does not survive for long. In other words, this is exactly the kind of story worth paying attention to if you want to separate real AI adoption from PowerPoint theater. Why this partnership is more than headline bait Drug development is slow, expensive, and brutally uncertain. Anything that helps researche...